6-Bromo-2-(4-nitro-phenyl)-benzo[d][1,3]oxazin-4-one | 80306-90-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 6-Bromo-2-(4-nitro-phenyl)-benzo[d][1,3]oxazin-4-one
• 英文别名: 6-Bromo-2-(4-nitrophenyl)-3,1-benzoxazin-4-one
• CAS: 80306-90-7
• 化学式: C₁₄H₇BrN₂O₄
• 分子量: 347.125
• InChiKey: BKVWBWMCOMLNRY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  21
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  84.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  6-Bromo-2-(4-nitro-phenyl)-benzo[d][1,3]oxazin-4-one 以 吡啶 为溶剂， 生成 2-Bromo-6-(4-nitro-phenyl)-benzo[4,5]imidazo[1,2-c]quinazoline
  参考文献：
  名称：

  Rao, A. Raghu Ram; Bahekar, Rajesh H., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1999, vol. 38, # 4, p. 434 - 439

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氨基-5-溴苯甲酸 、 4-硝基苯甲酰氯 在 吡啶 作用下， 以85%的产率得到6-Bromo-2-(4-nitro-phenyl)-benzo[d][1,3]oxazin-4-one
  参考文献：
  名称：

  Rao, A. Raghu Ram; Bahekar, Rajesh H., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1999, vol. 38, # 4, p. 434 - 439

  摘要：

  DOI：

文献信息

• GUPTA, R. C.;SAXENA, A. K.;GUPTA, M. B.;SHANKER, K.;BHARGAVA, K. P.;KISHO+, PROC. NAT. ACAD. SCI., INDIA, 1980, 50, N 4, 189-194
  作者：GUPTA, R. C.、SAXENA, A. K.、GUPTA, M. B.、SHANKER, K.、BHARGAVA, K. P.、KISHO+

  DOI：——

  日期：——
• Synthesis of Some Noval Qunazolinone Derivatives for their Anticonvulsant Activity
  作者：Phool Singh Yaduwanshi、Sheelu Singh、Prinsi Sahapuriya、Priyanka Dubey、Jyoti Thakur、Savita Yadav

  DOI：10.13005/ojc/400207

  日期：2024.4.30

  The quinoline family comprises an appealing group of heterocyclic compounds, with quinazolinones and their synthetic analogs being of particular interest. To synthesize 3- amino 2-phenyl quinazolinones, anthranilic acid and its substituted derivatives were employed as initial materials. The MES method was utilized to evaluate the anticonvulsant activity of the developed substances on albino mice, with phenytoin serving as a benchmark anticonvulsant medication.The synthesized compounds demonstrated noteworthy anticonvulsant activity, comparable to that of established prescription medications. Among these compounds, Compound A-1 exhibited the highest level of activity. This indicates the potential of these synthetic analogs as effective anticonvulsants, with Compound A-1 standing out as particularly promising in this regard.Preliminary results indicate that certain quinazolinone derivatives exhibited promising anticonvulsant effects in the MES test. Further investigation into the mechanism of action and safety profile of these compounds is underway. The structure-activity relationships deduced from this study may guide the design of future anticonvulsant agents based on the quinazolinone scaffold.This research contributes to the ongoing efforts to discover new therapeutic options for epilepsy and provides valuable insights into the potential of quinazolinone derivatives as anticonvulsant agents. The findings underscore the importance of exploring diverse chemical structures in the quest for improved treatments for neurological disorders.